LBX Pharmacy Chain Joint Stock Company (SHSE:603883) entered into an agreement to acquire remaining 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. from Cui Xufang and Xu Yuping for CNY 68.9 million on July 16, 2021. After the transaction is approved and implemented, LBX Pharmacy need to complete the payment of the equity transfer price as agreed by the two parties after the agreement takes effect, after the completion of the settlement, and after the completion of the completion of the acquisition involving all tax and fee payment obligations. Upon completion, LBX Pharmacy will hold 100% stake in Jiangsu Baijiahui. In related transactions, LBX Pharmacy Chain Joint Stock Company agreed to acquire remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. and 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. The transaction was funded by own funds of LBX Pharmacy. The transaction is subject to approval from shareholders of LBX Pharmacy and other possible approvals or approvals (if any) required by relevant laws and regulations. The transaction has been approved by the Board of LBX Pharmacy. As of August 20, 2021, shareholders of LBX Pharmacy Chain Joint Stock Company has approved the transaction.
Wei Qinghua of DONGXING SECURITIES Company Limited (SHSE:601198) acted as financial advisor to LBX Pharmacy. Ding Shaobo, Xie Yongjun, Wu Juan, Wang Tianjiao, Zhao Chengjie of Hunan Qiyuan Law Firm acted as legal advisor; Li Dan, Chen Jianxiang, Shen Jing of PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) acted as accountant and Hu Shaoxian, Zhao Jiao, Zhou Ya of Pan-China Certified Public Accountants and Fang Wensen, Chen Zhi, Wang Weihua of Zhongshenhua Certified Public Accountants (Special general partnership) acted as accountant to LBX Pharmacy. Hu Jiahao, He Yuanquan and Xie Songsha of Zhongrui Shilian Assets Appraisal Group Co., Ltd. acted as the appraisers for LBX Pharmacy Chain Joint Stock Company.